Plain-English translation of NCT06956326 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether people with multiple sclerosis who have recently had a relapse (a sudden worsening of symptoms) benefit more from intensive, closely supervised physical therapy compared to standard rehabilitation care. You would participate in either a specialized 10-week program with two supervised therapy sessions per week, or continue with usual care, while researchers measure how well you recover.
MS relapses can cause significant disability and loss of function. Researchers want to know if providing early, intensive rehabilitation tailored specifically for MS patients—rather than standard physical therapy—can help people recover better and improve their quality of life.
You likely qualify if…
You likely don't qualify if…
You would commit to 10 weeks of either intensive physical therapy or usual care. If assigned to the intensive program, you would attend two supervised physical therapy sessions per week, each lasting 45–60 minutes, with exercises designed specifically for your needs and planned together with MS specialists and your local physical therapist. If assigned to usual care, you would continue with standard municipal rehabilitation and self-directed exercises at home.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Denmark